Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Cartherics: Leading the Charge in Immunotherapy for Solid Tumours
By Karen Loudon / March 19, 2024
At Emergence 2024, Cartherics’ COO, Dr Ian Nisbet was interviewed by Wholesale Investor. In the interview, Ian discusses the company's...
Read More
Teal Ribbon Day: Raising awareness for ovarian cancer
By Karen Loudon / February 28, 2024
Each year in Australia around 1815 women are diagnosed with ovarian cancer. In most cases the cancer will be diagnosed...
Read More
Cartherics to present and exhibit at Emergence 2024
By Karen Loudon / February 22, 2024
Cartherics is pleased to announce that it will be attending Emergence 2024 – The Era of Abundance investment conference at...
Read More
